Target Price | $3.00 |
Price | $0.47 |
Potential |
543.78%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target bluebird bio, Inc. 2025 .
The average bluebird bio, Inc. target price is $3.00.
This is
543.78%
register free of charge
$6.00
1,187.55%
register free of charge
$1.00
114.59%
register free of charge
|
|
A rating was issued by 10 analysts: 3 Analysts recommend bluebird bio, Inc. to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the bluebird bio, Inc. stock has an average upside potential 2025 of
543.78%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 29.50 | 80.77 |
719.44% | 173.80% | |
EBITDA Margin | -1,046.34% | -329.93% |
90.07% | 68.47% | |
Net Margin | -1,268.30% | -336.73% |
93.05% | 73.45% |
9 Analysts have issued a sales forecast bluebird bio, Inc. 2024 . The average bluebird bio, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an bluebird bio, Inc. EBITDA forecast 2024. The average bluebird bio, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 bluebird bio, Inc. Analysts have issued a net profit forecast 2024. The average bluebird bio, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.93 | -1.40 |
43.07% | 27.46% | |
P/E | negative | |
EV/Sales | 4.15 |
10 Analysts have issued a bluebird bio, Inc. forecast for earnings per share. The average bluebird bio, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the bluebird bio, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
bluebird bio, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.